Alphyn Biologics, Inc.
Pharmaceutical company · Annapolis, Maryland, United States
Alphyn Biologics, Inc. is a pharmaceutical company headquartered in Annapolis, Maryland, United States. Its earliest recorded incorporation is in 2019. It has received 1 NIH small-business research grant, $1.1 million in total. It has reported private securities offerings to the US SEC, most recently $1.2 million sold in a notice filed in 2024.
Alphyn Biologics at a glance
What does Alphyn Biologics do?
US government research funding
1 NIH small-business research grant, $1.1 million in total. NIH funding came from the National Center for Complementary and Integrative Health.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $1.2 million sold (2024).
Frequently asked questions about Alphyn Biologics
Where is Alphyn Biologics headquartered?
Alphyn Biologics, Inc. is headquartered in Annapolis, Maryland, United States.
What does Alphyn Biologics do?
Alphyn Biologics, Inc. is a pharmaceutical company.
When was Alphyn Biologics founded?
The earliest incorporation on record for Alphyn Biologics, Inc. is in 2019, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences